China
· Delayed Price · Currency is CNY Shenzhen Mindray Bio-Medical Electronics Statistics
Total Valuation
Shenzhen Mindray Bio-Medical Electronics has a market cap or net worth of CNY 281.06 billion. The enterprise value is 268.62 billion.
| Market Cap | 281.06B |
| Enterprise Value | 268.62B |
Important Dates
The next estimated earnings date is Tuesday, April 29, 2025.
| Earnings Date | Apr 29, 2025 |
| Ex-Dividend Date | Nov 7, 2024 |
Share Statistics
Shenzhen Mindray Bio-Medical Electronics has 1.21 billion shares outstanding. The number of shares has increased by 0.07% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.21B |
| Shares Change (YoY) | +0.07% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 55.86% |
| Owned by Institutions (%) | 20.53% |
| Float | 495.54M |
Valuation Ratios
The trailing PE ratio is 22.75 and the forward PE ratio is 20.51. Shenzhen Mindray Bio-Medical Electronics's PEG ratio is 1.59.
| PE Ratio | 22.75 |
| Forward PE | 20.51 |
| PS Ratio | 7.59 |
| PB Ratio | 7.60 |
| P/TBV Ratio | 14.73 |
| P/FCF Ratio | 22.96 |
| P/OCF Ratio | n/a |
| PEG Ratio | 1.59 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.50, with an EV/FCF ratio of 21.95.
| EV / Earnings | 21.69 |
| EV / Sales | 7.24 |
| EV / EBITDA | 18.50 |
| EV / EBIT | 19.93 |
| EV / FCF | 21.95 |
Financial Position
The company has a current ratio of 2.34, with a Debt / Equity ratio of 0.01.
| Current Ratio | 2.34 |
| Quick Ratio | 1.86 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.02 |
| Debt / FCF | 0.02 |
| Interest Coverage | 733.61 |
Financial Efficiency
Return on equity (ROE) is 31.57% and return on invested capital (ROIC) is 21.22%.
| Return on Equity (ROE) | 31.57% |
| Return on Assets (ROA) | 15.66% |
| Return on Invested Capital (ROIC) | 21.22% |
| Return on Capital Employed (ROCE) | 29.28% |
| Revenue Per Employee | 2.06M |
| Profits Per Employee | 686,378 |
| Employee Count | 18,044 |
| Asset Turnover | 0.69 |
| Inventory Turnover | 2.85 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.26% in the last 52 weeks. The beta is 0.23, so Shenzhen Mindray Bio-Medical Electronics's price volatility has been lower than the market average.
| Beta (5Y) | 0.23 |
| 52-Week Price Change | -18.26% |
| 50-Day Moving Average | 251.80 |
| 200-Day Moving Average | 269.68 |
| Relative Strength Index (RSI) | 37.27 |
| Average Volume (20 Days) | 4,649,789 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Shenzhen Mindray Bio-Medical Electronics had revenue of CNY 37.11 billion and earned 12.38 billion in profits. Earnings per share was 10.22.
| Revenue | 37.11B |
| Gross Profit | 24.47B |
| Operating Income | 13.48B |
| Pretax Income | 13.87B |
| Net Income | 12.38B |
| EBITDA | 14.41B |
| EBIT | 13.48B |
| Earnings Per Share (EPS) | 10.22 |
Balance Sheet
The company has 17.66 billion in cash and 300.83 million in debt, giving a net cash position of 17.36 billion or 14.35 per share.
| Cash & Cash Equivalents | 17.66B |
| Total Debt | 300.83M |
| Net Cash | 17.36B |
| Net Cash Per Share | 14.35 |
| Equity (Book Value) | 42.01B |
| Book Value Per Share | 30.59 |
| Working Capital | 15.54B |
Cash Flow
In the last 12 months, operating cash flow was 14.36 billion and capital expenditures -2.12 billion, giving a free cash flow of 12.24 billion.
| Operating Cash Flow | 14.36B |
| Capital Expenditures | -2.12B |
| Free Cash Flow | 12.24B |
| FCF Per Share | 10.12 |
Margins
Gross margin is 65.92%, with operating and profit margins of 36.32% and 33.37%.
| Gross Margin | 65.92% |
| Operating Margin | 36.32% |
| Pretax Margin | 37.38% |
| Profit Margin | 33.37% |
| EBITDA Margin | 38.83% |
| EBIT Margin | 36.32% |
| FCF Margin | 32.98% |
Dividends & Yields
This stock pays an annual dividend of 7.21, which amounts to a dividend yield of 3.10%.
| Dividend Per Share | 7.21 |
| Dividend Yield | 3.10% |
| Dividend Growth (YoY) | -18.07% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 96.53% |
| Buyback Yield | -0.07% |
| Shareholder Yield | 3.03% |
| Earnings Yield | 4.41% |
| FCF Yield | 4.36% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Shenzhen Mindray Bio-Medical Electronics has an Altman Z-Score of 15.46.
| Altman Z-Score | 15.46 |
| Piotroski F-Score | n/a |